GO:1904493 tetrahydrofolyl-poly(glutamate) polymer binding

GO:1904493, tetrahydrofolyl-poly(glutamate) polymer binding, is a molecular_function term in the Gene Ontology that describes the selective interaction of a protein with tetrahydrofolyl-poly(glutamate) polymers. These polymers consist of a reduced folate core (tetrahydrofolate) conjugated to a chain of glutamate residues, a modification that enhances cellular retention and enzyme affinity. The term captures a binding event that is central to folate metabolism, one-carbon transfer, and nucleotide biosynthesis. Researchers study this activity to understand how cells acquire, store, and utilize folates, and how defects in these processes contribute to disease. The QuickGO definition states that this function is "Binding to tetrahydrofolyl-poly(glutamate) polymer". Because the term is a binding activity, it does not imply catalysis; rather, it describes a recognition event that can regulate enzyme activity, transport, or signaling. In this article, we synthesize the current understanding of GO:1904493, its associated genes, and the experimental strategies used to investigate it.

In our own words, GO:1904493 describes the ability of a protein or molecular complex to non-covalently and selectively bind tetrahydrofolyl-poly(glutamate) polymer, a polyglutamylated form of tetrahydrofolate. This binding is typically mediated by a folate-binding pocket that recognizes the pteridine ring and the polyglutamate tail. The term is a child of folate binding and is specific to the polyglutamylated form, distinguishing it from binding to monoglutamylated folates. It is used in annotations to indicate that a gene product participates in folate-dependent processes such as one-carbon metabolism, methionine synthesis, and thymidylate synthesis.

GO:1904493 is important because tetrahydrofolyl-poly(glutamate) polymers are the dominant intracellular folate species and the preferred substrates for key enzymes in one-carbon metabolism, including serine hydroxymethyltransferase, methylenetetrahydrofolate reductase, and thymidylate synthase. Binding of these polymers by specific proteins regulates folate homeostasis, compartmentalization, and flux through biosynthetic pathways. Consequently, this molecular function is critical for DNA synthesis, amino acid metabolism, and methylation reactions, and its perturbation is associated with developmental defects, cancer, and neurological disorders.

The following genes encode proteins that have been associated with tetrahydrofolyl-poly(glutamate) polymer binding or related folate metabolism, based on published literature.

The binding of tetrahydrofolyl-poly(glutamate) polymers is regulated at multiple levels. Expression of folate receptors and transporters is controlled by transcription factors responsive to folate status, such as the folate-responsive transcription factor TFAP2. Additionally, the polyglutamylation state of folates, determined by the balance between folylpolyglutamate synthase (FPGS) and gamma-glutamyl hydrolase (GGH), directly influences the availability of the polymer for binding. Cellular pH and redox status also modulate binding affinity, as seen in endosomal folate release. Furthermore, post-translational modifications of folate-binding proteins can alter their localization and interaction with folate.

Altered expression of folate-binding proteins and enzymes that interact with tetrahydrofolyl-poly(glutamate) polymers contributes to cancer progression and resistance to antifolate drugs such as methotrexate and 5-fluorouracil. For example, decreased FPGS activity reduces polyglutamylation and antifolate retention, leading to drug resistance. Conversely, overexpression of folate receptors can enhance folate uptake and support rapid tumor growth.

Impaired folate metabolism, including defects in polyglutamylation and binding, is associated with neural tube defects and other congenital anomalies. Polymorphisms in MTHFR and MTHFD1, which affect the availability of tetrahydrofolyl-poly(glutamate) for one-carbon transfer, are risk factors for these conditions. Folate supplementation reduces the incidence of neural tube defects, underscoring the importance of this binding activity.

Folate deficiency and disrupted folate metabolism have been linked to neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Reduced binding of tetrahydrofolyl-poly(glutamate) may impair methylation reactions and nucleotide synthesis in neurons, contributing to cognitive decline. However, the precise mechanisms remain under investigation.

Direct binding of tetrahydrofolyl-poly(glutamate) to proteins can be measured using radiolabeled folate derivatives, surface plasmon resonance (SPR), or isothermal titration calorimetry (ITC). These methods provide quantitative affinity constants and stoichiometry.

X-ray crystallography and cryo-electron microscopy have been used to determine the structures of folate-binding proteins in complex with polyglutamylated folates, revealing the molecular basis of recognition. NMR can also probe conformational changes upon binding.

Stable isotope tracing with 13C-labeled serine or formate can quantify one-carbon flux through folate-dependent pathways, indirectly assessing the functional impact of tetrahydrofolyl-poly(glutamate) binding. This approach is often combined with CRISPR knockout of candidate genes.

Genome-wide CRISPR knockout or activation screens in cells grown under folate-limited conditions can identify genes required for folate binding and metabolism. Such screens have uncovered novel regulators of folate uptake and polyglutamylation.

Researchers studying tetrahydrofolyl-poly(glutamate) polymer binding-related genes often need to determine whether a candidate gene is causally involved in folate metabolism, transport, or disease. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation of genes annotated with GO:1904493.

GO:1904493, tetrahydrofolyl-poly(glutamate) polymer binding, represents a critical molecular function in folate metabolism, enabling cells to recognize and utilize polyglutamylated folates for one-carbon transfer, nucleotide synthesis, and methylation. Dysregulation of this binding activity is implicated in cancer, developmental disorders, and neurodegeneration. Advances in CRISPR-based models and structural biology continue to illuminate the mechanisms and therapeutic potential of targeting this interaction.